This May, more than 100 fellows and junior faculty members flocked to the 2019 North American Young Rheumatology Investigator Forum held in Destin, Fla., where they presented their original research in oral and poster sessions.
From the dozens of abstracts submitted this year, an international panel of rheumatology experts selected 11 abstract authors to present their research and findings to an audience of their peers. Each abstract was meticulously judged for content quality, use of research concepts and extension of learning, practical applications and contributions to the field, learning potential, and applicability and relevance to clinical practice.
In addition, the expert panel awarded cash prizes and an iPad to those they judged to be the top four posters and best three oral presentations. Lead authors of the Top 11 Abstracts have also been invited to join Healio Rheumatology’s pool of experts, where we hope to share their insight and clinical experience with our readers.
Congratulations to the 2019 Award Winners and we look forward to seeing you at next year’s event!
Top 11 Abstract Winners
Didem Saygin, MD
A new tool to assess muscle strength in polymyositis and dermatomyositis: Handheld dynamometry
Yael Klionsky, MD
Statin therapy in systemic lupus erythematosus (SLE) patients: Cross-sectional analysis of a large population database
Deepan Dalal, MD, MPH
Trends in Medicare spending on disease modifying agents used to treat rheumatoid arthritis
Nitasha Kumar, MD
Distinct T follicular helper cell subset infiltrated the joints and peripheral blood in experimental inflammatory arthritis and were inhibited by a small molecule inhibitor
Alisha Gupta, MD, MBBS
Association of hydroxychloroquine use and incident atrial fibrillation in rheumatoid arthritis: A retrospective study
Nancy S. Harrison, MD
Missed opportunity? Evaluation for systemic autoimmune diseases with uveitis may not be optimal
Mukund Kumar, MBBS
Causes and predictors of 30-day and 90-day readmission rates for ANCA associated vasculitis insights from nationwide readmission database
Hamdy Ahmed, MD
Systematic lupus erythematosus patients with common variable immunodeficiency disease
Patricia Kachur, MD
Is gout a risk factor for development of cancer?
Anam Umar, MD
Influenza and pneumococcal vaccines in patients with systemic lupus erythematosus: Findings from a large urban public hospital
Ricky Mehta, MD
Should rheumatoid factor and anti-CCP antibodies be repeated in patients with a diagnosis of seronegative inflammatory arthritis?
Mohammed Fassehuddin, DO
Organic anion transport inhibitors suppress chondrocyte pyrophosphate production
Kimberly Staudt, MD
Efficacy of infliximab in chronic inflammatory arthritis following parvovirus B19 infection
Jonathan A. Aun, DO
Felty’s syndrome conundrum: Large granular lymphocytic leukemia
Whitney Bembry, MD, MPH
Should a subset of Podocytopathy in stage 2 MCD be added in the LN ISN Renal Pathology Society classification?
Shraddha Jatwani, MD
Rheumatoid arthritis associated with longer hospital stays in patients admitted with venous thromboembolism: A nationwide analysis 2010-2014
Rouhin Sen, MD
Acute major cardiovascular events in rheumatoid arthritis, gout and osteoarthritis: A retrospective study using the national inpatient sample from 2002-2016
Mohamed Tageldin, MBBCh
Cardiovascular risk assessment in giant cell arteritis
Razan Alif, MD
What’s in the Granuloma?
Dilli Ram Poudel, MD
All-cause hospitalizations in systemic lupus erythematosus in the US: Results from National Inpatient Database
Taylor Faulk, MD
A picture is worth a thousand words: Diagnosing an arthritis dominant variant of familial Mediterranean fever
Manan Dhingra, MD
A rare and instructive case of sarcoid-lymphoma syndrome
James Dizmang, MD
Dual-energy computed tomography for diagnosis of gout arthritis following negative joint aspiration
Marissa Sansone, MD
Myopathy, it may not be what it seems
Judith Aniekwena, MD
Atypical therapy response in bullous systemic lupus
Harman Fervaha, MD
Successful treatment of new onset lupus nephritis in pregnancy with rituximab